An implantable vagus nerve-targeted device safely reduces disease activity and joint damage in rheumatoid arthritis, offering a new nondrug treatment for patients who do not respond to or cannot tolerate medication.
- John R. P. Tesser
- Angela R. Crowley
- David Chernoff
